 |
|
Genentech is among the world's leading biotech companies, with multiple protein-based products on the market for serious or life-threatening medical conditions. Genentech licensed FermWorks for bioreactor control across a variety of labs at its South San Francisco facilities. |
| Genentech |
|
|
| |
|
|
 |
|
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The Bayer FermWorks installation includes a customized Expert System, created by Jova Solutions, that provides a natural-language method of controlling bioreactor processes. |
| Bayer |
|
|
| |
|
|
 |
|
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. BioMarin licensed FermWorks for bioreactor control in its development laboratories at its Novato, CA facilities. |
| BioMarin |
|
|
| |
|
|
 |
|
Novozymes is the biotech-based world leader in enzymes and microorganisms, developing enzymes for industrial processes. Novozymes licensed FermWorks for bioreactor control in its development laboratories at its Davis, CA facilities. |
| Novozymes |
|
|
| |
|
|
 |
|
MIT (Massachusetts Institute of Technology) is a world-class educational institution advancing knowledge in science, technology, and other areas of scholarship that will best serve the
nation and the world in the 21st century. MIT licensed FermWorks for bioreactor control in its laboratories at its Cambridge, MA campus. |
| MIT |
|
|
| |
|
|
 |
|
NexBio develop broad-spectrum prophylaxis and
therapeutics for the prevention and treatment of life threatening human
respiratory infectious diseases. NexBio licensed FermWorks for bioreactor control in its development laboratories at its San Diego, CA facilities. |
| NexBio |
|
|
| |
|
|
 |
|
Centocor, a subsidiary of Johnson and Johnson. Centocor has been a leader in the field of biomedicines for more than 25 years. |
| Centocor |
|
|
| |
|
|
 |
|
ZeaChem, Inc. is developing a novel, patent protected, technology platform using innovative fermentation and chemical process technologies for the conversion of cellulosic biomass to ethanol which is carbon, energy and cost efficient. Incorporated in 2002, ZeaChem has a laboratory and pilot plant in the bay area of San Francisco, California. |
| ZeaChem |
|
|
|
| |
|
|
